Blog

Eliminate Allergy and Asthma Triggers From Schools to Support National Healthy Schools Day

Asthma is the main reason why children miss school. In fact, children in the U.S. miss about 13.8 million school days each year due to asthma. Missing school can affect many children's grades and well-being. Controlling asthma triggers at home can help reduce asthma symptoms. But what about at school? If kids are exposed to triggers at school, managing asthma at home will be a losing battle. Children are the most affected by air pollution and poor indoor air quality. The Asthma and Allergy...

FDA Approves Dupixent® for Moderate-to-Severe Atopic Dermatitis in Adolescents

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids.

AAFA Offers Free Online Course for Severe Asthma

Severe ASTHMA (Asthma Symptoms, Treatment, Health Management and Activities™) Care for Adults is a FREE self-paced course that helps adults and their caregivers learn how to manage severe asthma. It explains severe and uncontrolled asthma, the impact of severe asthma, asthma management plans and severe asthma treatments.

You’re Invited: Virtual Film Screening and Panel Discussion on “Asthma Alley”

Join the Asthma and Allergy Foundation of America (AAFA), American Lung Association, Allergy & Asthma Network and GroundTruth Films for a virtual film screening of “Asthma Alley,” a short documentary that follows a young teen with asthma and her classmates in the South Bronx, a neighborhood known for extraordinarily high rates of asthma.

×
×
×
×